Related Experiment Video
Updated: Dec 12, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
SLCO4A1-AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR-4701-5p/NFE2L1 axis
Yuxuan Wei1, Li Wei2, Jiwei Li2
1Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, Lanzhou, China.
Abstract:
Long noncoding RNAs (lncRNAs) possessed essential functions in the biological behaviors of various human cancers. SLCO4A1 antisense RNA 1 (SLCO4A1-AS1) is a lncRNA that has been reported as a oncogenic regulator in colorectal cancer and bladder cancer. However, whether it exerted functions in the gene expression and cellular processes in lung adenocarcinoma (LUAD) remains still obscure. In the present research, we unveiled the high level of SLCO4A1-AS1 in LUAD tissues and cells. Moreover, functional assays indicated that SLCO4A-AS1 facilitated LUAD cell proliferation, motility, and cisplatin-resistance. Besides, mechanism investigation revealed that miR-4701-5p could interact with SLCO4A1-AS1 and directly target to NFE2L1. The expression correlation between miR-4701-5p and SLCO4A1-AS1 or NFE2L1 was found to be negative. Moreover, NFE2L1 was expressed at a same tendency with SLCO4A1-AS1 in LUAD tissues and cells. In addition, it was confirmed that NFE2L1 was involved in SLCO4A1-AS1-mediated activation of WNT pathway. According to rescue assays, NFE2L1 could involve in SLCO4A1-AS1-mediated LUAD cell growth. Conclusively, our study demonstrated that SLCO4A1-AS1 facilitated cell growth and enhanced the resistance of LUAD cells to chemotherapy via activating WNT pathway through miR-4701-5p/NFE2L1 axis.
Insights
Long noncoding RNA SLCO4A1-AS1 promotes lung adenocarcinoma (LUAD) growth and chemoresistance. It activates the WNT pathway by interacting with miR-4701-5p and targeting NFE2L1, driving LUAD progression.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Long noncoding RNAs (lncRNAs) play crucial roles in human cancer development.
- SLCO4A1 antisense RNA 1 (SLCO4A1-AS1) is implicated as an oncogenic regulator in other cancers, but its role in lung adenocarcinoma (LUAD) is unknown.
Purpose of the Study:
- To investigate the function and mechanism of SLCO4A1-AS1 in lung adenocarcinoma (LUAD).
- To explore the potential of SLCO4A1-AS1 as a therapeutic target in LUAD.
Main Methods:
- Quantitative real-time PCR to assess SLCO4A1-AS1 expression levels in LUAD tissues and cells.
- In vitro functional assays (proliferation, migration, cisplatin resistance) to evaluate the impact of SLCO4A1-AS1.
- Mechanism studies including RNA immunoprecipitation, luciferase reporter assays, and Western blotting to elucidate the interaction between SLCO4A1-AS1, miR-4701-5p, and NFE2L1.
- Rescue experiments to confirm the role of NFE2L1 in SLCO4A1-AS1-mediated effects.
Main Results:
- SLCO4A1-AS1 was significantly upregulated in LUAD tissues and cells.
- SLCO4A1-AS1 overexpression promoted LUAD cell proliferation, migration, and cisplatin resistance.
- SLCO4A1-AS1 interacted with miR-4701-5p, which directly targeted NFE2L1.
- NFE2L1 expression was positively correlated with SLCO4A1-AS1 and involved in SLCO4A1-AS1-induced LUAD cell growth via WNT pathway activation.
Conclusions:
- SLCO4A1-AS1 acts as an oncogene in LUAD by promoting cell growth and chemoresistance.
- The SLCO4A1-AS1/miR-4701-5p/NFE2L1 axis, involving WNT pathway activation, is a key mechanism driving LUAD progression.
- SLCO4A1-AS1 represents a potential therapeutic target for lung adenocarcinoma.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
